Answer
During ALTUVOCT 250 IU (efanesoctocog alfa) treatment, plasma factor VIII activity monitoring is required for major surgery or life-threatening bleeds to guide the dose and frequency of repeated injections, but is usually unnecessary for dose adjustment during routine prophylaxis.
Sources for this answer
- ALTUVOCT 250 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked